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The Environmental Genome
Project: Suggestions and
Concerns
The NIEHS held a Symposium on the
Environmental Genome Project on 17-18
October 1997 at the National Institutes of
Health in Bethesda, Maryland. The pur-
pose ofthe meeting was to facilitate a free
exchange of information about the
Environmental Genome Project among "a
diverse group of scientists working in the
areas of genetics, gene-environment inter-
actions, molecular epidemiology, and
issues ofgenetic testing" (1). After attend-
ing this meeting and reading the recent
reports on the Environmental Genome
Project in Science (2) and Nature (3), we
are concerned that several important issues
ofinterest to the readers ofEnvironmental
Health Perspectives are not being adequate-
lyaddressed bythe NIEHS.
The goal of the Environmental
Genome Project is to "facilitate identifica-
tion of functionally important polymor-
phisms in environment response genes that
may determine differences in disease risks
to environmental exposures" (1). To this
end, the NIEHS proposes to establish a
repository of1,000 anonymous DNA sam-
ples representing the population of the
United States in order to catalog allelic
variants in 200 genes and foster epidemio-
logic studies ofgene-environment interac-
tions in the etiology ofhuman diseases. At
the symposium and in the Science article
(2), thepotential importance ofgene-envi-
ronment interactions in various diseases
was recognized and the potential benefits
of a central repository ofdata on a set of
critical risk-mediating genes were clearly
enunciated. Two issues, however, have not
been adequately addressed: sample size and
public policyimplications.
We have serious doubts that the
Environmental Genome Project's proposed
sample size of 1,000 individuals is large
enough to provide stable estimates ofallele
frequencies in subgroups ofthe population.
Many ofthe most promising candidate sus-
ceptibility genes have allelic variations that
affect less than 5% ofthepopulation, and the
prevalence ofmany ofthese polymorphisms
differs markedly among ethnic groups. If1%
ofthe people in the U.S. population carry a
polymorphism for a certain gene, for exam-
ple, we would expect 10 individuals out of
the 1,000 individuals in the study to carry
thatpolymorphism. Ifthose 10 arethen to be
subdivided into gender/racial/ethnic/sub-
groups, thesamplesizeisdearlyinadequateto
provide precise estimates ofthe prevalence of
the polymorphism in the subgroups. Yet pre-
cise estimates ofthepopulation prevalence are
exactly the kind ofinformation needed by
epidemiologists planningstudies oftheroleof
such genes in disease etiologies. That infor-
mationisoftendifficult tofindornonexistent
in the current literature, much ofwhich is
characterized by small, nonpopulation-based
studies thataredifficult to generalize. It is dif-
ficult to conceive why the Environmental
Genome Project would spend so much time
and money only to find that 1,000 subjects
were not nearly enough. Given the potential
importance of this population-based data,
and cognizant ofthe budgetary constraints, it
would seem wiser to ensure the value ofthe
data by increasing the sample size and
decreasing the number ofgenes targeted for
sequencing.
Concerning the sampling procedure,
the NIEHS appears to have planned to
collect samples from individuals rather
than using existing archived samples. This
will involve a considerable expense. An
alternative, cost-saving strategy, which
does not appear to have been seriously
explored, would be to use the archived
lymphocyte cell lines from the National
Health and Nutrition Examination Survey
(NHANES) III study as the source of
DNA for the Environmental Genome
Project. The NHANES III study popula-
tion is large (over 8,000) and is popula-
tion-based, a representative sample of the
entire U.S. population. A further advan-
tage ofusing this database is that genotype
data can be linked to an enormous data-
base of health and nutrition variables.
Strategies for preserving anonymity are
currently being investigated by the Centers
for Disease Control and Prevention.
We are also concerned about the societal
ramifications ofthe Environmental Genome
Project. 'While the recent symposium did
address certain ethical and policy issues such
as insurance discrimination, other issues
unique to the Environmental Genome
Project received little attention. One of the
project's goals is to improve risk assessment
and regulation by government agencies
through specific information about vulnera-
ble populations. How this information is to
be used in risk-based regulation in a hetero-
geneous society is as yet unclear. Should
employers be able to transfer chemicallysen-
sitive workers to jobs with lower exposure
levels rather than reducing exposure levels to
a safe level for all? Could employers expose
more resistant workers to higher exposure
levels? In cases ofalleged chemical injury,
would lawyers misuse knowledge ofgenetic
susceptibilities? The Environmental
Genome Project, ofcourse, cannot be held
accountable for such misuses, but since the
project aims to follow the lead of the
Human Genome Project in channeling
some of its resources into exploring ethical
concerns, it seems logical to focus on ethical
issues specific to the Environmental
Genome Project before work progresses fur-
ther. This may require educating courts and
regulators about what can and cannot be
known about risk-mediating genes in given
individuals andpopulations.
Basic scientists have rarely had to
address broad public policy issues resulting
from their investigations, but genetics has
increasingly become, like epidemiology, as
much a tool forpublic health as a scientific
discipline. The point on which everyone
seems to agree is that improving public
health is the primary goal of biomedical
research. It will take careful thinking to
ensure that the Environmental Genome
Project serves this purpose.
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Response: Environmental
Genome Project
The letter from Loffredo, Silbergeld, and
Parascandola raises several interesting issues
that I would like to address in the context
ofthe overall concept ofthe Environmental
Genome Project. The Environmental
Genome Project is an outgrowth ofa long-
standing interest on the part ofthe NIEHS
and the larger scientific community in the
relationship between environmental expo-
sure and disease and the influence ofgenet-
ics upon this relationship. In their letter,
Loffredo, Silbergeld, and Parascandola
express concern about whether the sample
size proposed for initial studies by the
Environmental Genome Project is suffi-
cient for assignment of allele frequencies,
and they urge caution in dealing with the
ethical, social, and legal implications ofthe
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